Loading...

CytoTools AG

T5O.DE•XETRA
Healthcare
Biotechnology
€0.32
€0.00(0.00%)

CytoTools AG (T5O.DE) Stock Overview

Explore CytoTools AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap164.4K
P/E Ratio-0.01
EPS (TTM)$-1.29
ROE-1.91%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.18

T5O.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CytoTools AG (T5O.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.18.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 164.4K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;